|
GLE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.298400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.842400E-01 |
| Normal-vs-Stage2 |
9.065400E-01 |
| Normal-vs-Stage3 |
1.423700E-02 |
| Normal-vs-Stage4 |
2.200800E-01 |
| Stage1-vs-Stage2 |
7.783800E-01 |
| Stage1-vs-Stage3 |
2.339100E-03 |
| Stage1-vs-Stage4 |
1.021430E-01 |
| Stage2-vs-Stage3 |
8.404100E-02 |
| Stage2-vs-Stage4 |
3.251000E-01 |
| Stage3-vs-Stage4 |
5.615800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.909200E-01 |
| Normal-vs-AfricanAmerican |
1.223980E-01 |
| Normal-vs-Asian |
7.766200E-02 |
| Caucasian-vs-AfricanAmerican |
3.072000E-01 |
| Caucasian-vs-Asian |
2.719800E-01 |
| AfricanAmerican-vs-Asian |
8.759600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.973600E-02 |
| Normal-vs-Female |
2.057400E-01 |
| Male-vs-Female |
3.263000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.364000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.771200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.328200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.522400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.025000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.628400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.673200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.464800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.723800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.816200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.266000E-02 |
| Normal-vs-Grade 2 |
4.280400E-01 |
| Normal-vs-Grade 3 |
3.669800E-01 |
| Normal-vs-Grade 4 |
1.401820E-03 |
| Grade 1-vs-Grade 2 |
1.682220E-01 |
| Grade 1-vs-Grade 3 |
8.338500E-02 |
| Grade 1-vs-Grade 4 |
4.336100E-03 |
| Grade 2-vs-Grade 3 |
1.125220E-01 |
| Grade 2-vs-Grade 4 |
8.42430000000949E-05 |
| Grade 3-vs-Grade 4 |
1.402460E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.53450000000199E-05 |
| Normal-vs-ccB subtype |
3.54889999998331E-06 |
| ccA subtype-vs-ccB subtype |
7.7715611723761E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.268200E-01 |
| Normal-vs-N1 |
8.304800E-01 |
| N0-vs-N1 |
7.852400E-01 |
|
|
